A Case of Poorly Differentiated Hepatocellular Carcinoma, Lymphocyte-rich.

Ginji Omori; Takahiro Osuga; Koji Miyanishi; Kota Hamaguchi; Shingo Tanaka; Hiroyuki Ohnuma; Kazuyuki Murase; Kohichi Takada; Minoru Nagayama; Yasutoshi Kimura; Ichiro Takemasa; Yasuhiro  Kikuchi; Toshihiko  Torigoe; Junji Kato

doi:10.22541/au.162276483.32566889/v1

loading page

A Case of Poorly Differentiated Hepatocellular Carcinoma, Lymphocyte-rich.

Ginji Omori,
Takahiro Osuga,
Koji Miyanishi,
Kota Hamaguchi,
Shingo Tanaka,
Hiroyuki Ohnuma,
Kazuyuki Murase,
Kohichi Takada,
Minoru Nagayama,
Yasutoshi Kimura,
Ichiro Takemasa,
Yasuhiro Kikuchi,
Toshihiko Torigoe,
Junji Kato

Abstract

A 70-year-old woman was diagnosed poorly differentiated hepatocellular carcinoma (HCC), lymphocyte rich. In this case, programmed cell death 1 expression was observed. Immune checkpoint inhibitor treatment may be effective in such cases, although there have been no reports of their use for poorly differentiated HCC, lymphocyte-rich.

24 May 2021Submitted to Clinical Case Reports

Show details

Hide details

25 May 2021Submission Checks Completed

25 May 2021Assigned to Editor

04 Jun 2021Reviewer(s) Assigned

20 Jul 2021Review(s) Completed, Editorial Evaluation Pending

30 Jul 2021Editorial Decision: Revise Minor

12 Aug 20211st Revision Received

13 Aug 2021Submission Checks Completed

13 Aug 2021Assigned to Editor

13 Aug 2021Review(s) Completed, Editorial Evaluation Pending

15 Aug 2021Editorial Decision: Accept

Abstract

Peer review status:ACCEPTED